From Delays to Results: Patient Watchtower™ and Omnichannel CRM Add 784 Patient Months in Liver Disease Specialty

A mid-sized U.S. pharmaceutical company supporting the liver disease specialty faced obstacles in increasing patient conversions and medication adherence, particularly for patients experiencing lengthy prescription processing times. The company needed to quantify system usage and measure the impact of intervention strategies on conversion rates and refill adherence.

• Managing patients stalled by long processing durations before receiving their first prescription fill.
• Increasing refill rates and overall patient retention, particularly for those affected by medication stock-outs and prolonged waiting times.
• Accurately quantifying the impact of patient interventions to ensure effective resource allocation and improved patient outcomes.

• 10,000 patient interventions quarterly with less than 2-day response time: The client patient services team maintains active system engagement, averaging 10,000 patient interventions quarterly, with an average response time of less than two days.
• +6 percentage point improvement in first fill rates for delayed patients: For patients waiting 31 or more days for their first prescription fill, Claritas Rx Ascend® patient intervention boosted the fill rate by 6 percentage points.
• +23 percentage point increase in refill rates, prolonging therapy duration: For patients classified as out of stock for over 51 days, the intervention platform increased their refill rate by 23 percentage points, prolonging therapy duration.

Through these targeted interventions, the client teams have added 784 incremental patient months for new patients enrolled and shipped.

Source: Claritas Rx, data on file, August 2025. Case study based on a mid-sized pharmaceutical company in the liver disease specialty.